Dr. Irit Ben-Aharon
MD, PhD
Director, Oncology Division & Joseph Fishman Oncology Center
corporate_fareRambam Health Care Campus, Haifa, Israel
Irit Ben-Aharon
MD, PhD
Prof. Irit Ben-Aharon is a senior medical oncologist and Director of the Joseph Fishman Oncology Center at Rambam Health Care Campus in Haifa, Israel — a 1,100-bed academic government hospital and the tertiary referral centre for 12 district hospitals across Northern Israel. Her clinical and research focus centres on gastrointestinal malignancies, with particular expertise in early-onset and young-onset GI cancers.
Prof. Ben-Aharon completed an MD-PhD joint programme through Tel Aviv University and the U.S. National Institutes of Health, obtaining a PhD in developmental biology. She completed her oncology residency at Rabin Medical Center and undertook GI cancer fellowship training at Memorial Sloan Kettering Cancer Center as a Fulbright Scholar. She has since built an internationally recognised academic career at the Rappaport Faculty of Medicine, Technion–Israel Institute of Technology, with a laboratory focused on young cancer patients, chemotherapy-related vascular and reproductive toxicity, and the biological drivers of early-onset GI cancers. In 2023, she was appointed Editor-in-Chief of ESMO Gastrointestinal Oncology, and she leads EORTC young-onset cancer task force activities.
CancerFax can coordinate medical-report review and consultation support for international patients seeking expert input from Prof. Ben-Aharon at Rambam Health Care Campus, subject to case acceptance and hospital availability.
Why Consider Prof. Irit Ben-Aharon?
Prof. Irit Ben-Aharon brings together clinical leadership of one of Israel's largest oncology centres, internationally recognised GI cancer research, and a dedicated focus on the needs of younger adults facing a cancer diagnosis.
Areas of Specialisation
Gastrointestinal cancers, early-onset malignancies, and complex oncology in young adults
Prof. Ben-Aharon's clinical expertise spans gastrointestinal oncology, with a particular focus on digestive system cancers in younger patients, oncofertility, and the long-term effects of cancer treatment on reproductive and vascular health.
Gastrointestinal Cancers
Comprehensive medical oncology for cancers of the digestive system, including colorectal, gastric, pancreatic, and hepatobiliary malignancies.
- arrow_rightEarly-onset and young-onset colorectal cancer, with focus on distinct biology and treatment needs
- arrow_rightStandard and investigational systemic therapy for advanced disease
- arrow_rightMultidisciplinary treatment planning with surgical and radiation oncology teams
- arrow_rightGastric, oesophageal, pancreatic, and hepatobiliary malignancies
- arrow_rightSystemic therapy planning including chemotherapy and targeted approaches where applicable
- arrow_rightParticipation in GI cancer clinical research programmes
Young-Onset Cancer Care
Dedicated clinical and research focus on younger adults diagnosed with cancer, with attention to fertility, long-term toxicity, pregnancy-related cancer, and survivorship.
- arrow_rightManagement of early-onset GI cancers with age-appropriate treatment planning
- arrow_rightSurvivorship and long-term toxicity monitoring for younger patients
- arrow_rightEORTC young-onset cancer task force leadership informing clinical best practices
- arrow_rightClinical and research expertise in treatment-related risks during pregnancy
- arrow_rightResearch into placental and fetal impact of chemotherapy exposure
- arrow_rightMultidisciplinary coordination for pregnancy-associated cancer care
Oncofertility & Treatment Toxicity
Research and clinical expertise in chemotherapy-related reproductive and vascular toxicity, and fertility preservation for cancer patients.
- arrow_rightFertility considerations in cancer treatment planning for younger patients
- arrow_rightResearch into chemotherapy-related reproductive toxicity
- arrow_rightCoordination with reproductive medicine for fertility preservation pathways
- arrow_rightResearch into chemotherapy-related vascular injury mechanisms
- arrow_rightLong-term survivorship monitoring for GI cancer patients
- arrow_rightAssessment and management of late treatment effects
Clinical Services & Procedures
Medical oncology, multidisciplinary GI cancer care, and research-driven treatment
The Joseph Fishman Oncology Center at Rambam provides a full range of oncology services including consultation, systemic therapy, radiotherapy, inpatient oncology care, and access to clinical research programmes.
Medical Oncology Consultation
Medical OncologySpecialist oncology consultation and systemic treatment planning for gastrointestinal and other cancers.
Multidisciplinary GI Cancer Care
MultidisciplinaryIntegrated tumour board review and collaborative management across surgical, radiation, and medical oncology teams.
Second Opinion for GI Cancer
Second OpinionIndependent expert review of pathology, molecular findings, imaging, and existing treatment plans for gastrointestinal cancers.
Survivorship & Long-Term Monitoring
MonitoringStructured survivorship planning and toxicity monitoring for GI cancer patients, with particular attention to younger adults.
Research & Publications
Internationally recognised contributions to GI oncology, early-onset cancer, and oncofertility
Prof. Ben-Aharon is a physician-scientist with over 114 research outputs and a laboratory at the Technion focused on young cancer patients, chemotherapy-related toxicity, and early-onset GI cancer biology.
Prof. Ben-Aharon's laboratory and editorial leadership at ESMO Gastrointestinal Oncology mean her clinical approach is directly informed by the latest research in GI cancer biology, early-onset malignancies, and treatment toxicity.
Education & Training
Prof. Ben-Aharon completed an MD-PhD joint programme through Tel Aviv University and the U.S. National Institutes of Health, followed by oncology training at Rabin Medical Center and fellowship training at Memorial Sloan Kettering Cancer Center as a Fulbright Scholar.
Clinical Experience
Prof. Ben-Aharon has built a career spanning clinical oncology leadership, translational research, and international academic engagement. She has served as Director of the Joseph Fishman Oncology Center at Rambam Health Care Campus since approximately 2018, while maintaining an active research laboratory and international editorial leadership.
How CancerFax Helps You Access Dr. Irit Ben-Aharon
CancerFax is a specialist cancer patient-navigation platform. We help international patients prepare structured medical summaries, assess treatment eligibility, and connect directly with Dr. Irit Ben-Aharon's team — with full coordination from initial inquiry to consultation.
Medical Report Review
Free review of your pathology results, imaging, molecular profiling, and treatment history — prepared as a structured clinical summary for Dr. Irit Ben-Aharon's team.
Treatment Eligibility Screening
CancerFax screens your case for eligibility for treatments and clinical programmes available through Dr. Irit Ben-Aharon before you travel, so you arrive with a clear pathway.
Case Submission
We coordinate direct case submission to Dr. Irit Ben-Aharon's department, including all documentation required for clinical review and appointment scheduling.
Appointment & Consultation Coordination
CancerFax manages appointment scheduling with Dr. Irit Ben-Aharon's team, confirming availability and aligning timelines with your travel plans.
Travel, Visa & Logistics Support
We prepare visa invitation letters, provide hospital-proximity accommodation guidance, and coordinate airport transfers for international patients.
Follow-Up & Continuity of Care
After your consultation or treatment, CancerFax facilitates communication between Dr. Irit Ben-Aharon's team and your home oncologist for seamless post-treatment follow-up.
Frequently Asked Questions About Prof. Irit Ben-Aharon
CancerFax can coordinate medical-report review and consultation support for international patients seeking an opinion from Prof. Ben-Aharon at Rambam Health Care Campus in Haifa, Israel, subject to hospital availability and case acceptance. Rambam has an International Medicine framework for supporting patients from abroad.
Prof. Ben-Aharon specialises in gastrointestinal malignancies including colorectal cancer, gastric cancer, pancreatic cancer, hepatobiliary cancers, and oesophageal cancer. She has a particular clinical and research focus on early-onset and young-onset GI cancers — those occurring in younger adults — as well as pregnancy-associated cancer and cancer survivorship.
Submit your medical reports through CancerFax using the Send Your Reports button. The CancerFax team will review your documents, prepare a structured case summary, and coordinate the next steps with Rambam Health Care Campus, subject to the hospital's availability and the nature of your case.
A second-opinion request can be submitted through CancerFax with the patient's pathology reports, molecular profiling results, imaging studies, treatment history, and relevant test results. Prof. Ben-Aharon is a senior GI cancer specialist; the final consultation format and availability depend on the hospital's processes and case acceptance.
Prof. Ben-Aharon's laboratory and clinical work specifically focus on early-onset gastrointestinal cancers and the needs of younger adults with cancer, including fertility preservation, long-term treatment toxicity, cancer during pregnancy, and survivorship. She also leads EORTC young-onset cancer task force activities, which inform clinical standards across Europe for this patient group.
Yes. Prof. Ben-Aharon is a Principal Investigator at the Rappaport Faculty of Medicine, Technion, with over 114 research outputs. Her laboratory focuses on early-onset GI cancer biology and chemotherapy-related vascular and reproductive toxicity. She is also Editor-in-Chief of ESMO Gastrointestinal Oncology and has contributed to landmark papers in Nature Reviews Cancer and AACR journals.
Connect with Irit Ben-Aharon Today
Share your medical reports for a free preliminary review. Our patient coordinators will help you understand your options and arrange a direct consultation.
Medical Disclaimer: Information on this page is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before making any medical decisions.